Ovarian Suppression for Women Younger Than 35 Years: New Data to Support Informed Decision Making

Affiliations

Editorial

Philip D Poorvu et al. J Clin Oncol. 2017.

. 2017 Sep 20;35(27):3092-3094.

doi: 10.1200/JCO.2017.73.5662. Epub 2017 Jun 30.

¹ Philip D. Poorvu and Ann H. Partridge, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.

No abstract available

Comment on

Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials.
Saha P, Regan MM, Pagani O, Francis PA, Walley BA, Ribi K, Bernhard J, Luo W, Gómez HL, Burstein HJ, Parmar V, Torres R, Stewart J, Bellet M, Perelló A, Dane F, Moreira A, Vorobiof D, Nottage M, Price KN, Coates AS, Goldhirsch A, Gelber RD, Colleoni M, Fleming GF; SOFT; TEXT Investigators; International Breast Cancer Study Group. Saha P, et al. J Clin Oncol. 2017 Sep 20;35(27):3113-3122. doi: 10.1200/JCO.2016.72.0946. Epub 2017 Jun 27. J Clin Oncol. 2017. PMID: 28654365 Free PMC article.